Comparison of bone marrow mesenchymal stem cells with bone marrow-derived mononuclear cells for treatment of diabetic critical limb ischemia and foot ulcer: A double-blind, randomized, controlled trial
['Cell treatment', 'Critical limb ischemia', 'Diabetes', 'Foot ulcer']
